Cipher Pharmaceuticals Inc(CPH-T)
TSX

Today's Change
Real-Time Last Update

Cipher Pharmaceuticals Inc

5750 Explorer Drive
Suite 404
Mississauga ON L4W 0A9 CAN
P: 905-602-5840
F: 905-602-0628
https://www.cipherpharma.com

Sectors & Indices

Sector
Industry
Employees

Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.

Key Executives

NameTitle
Craig MullCEO/Director
Bryan JacobsPresident
Hamed GhaneiOther Executive Officer
Ryan MaillingCFO/Secretary

More from The Globe

number cruncher
Searching for European momentum stocks in a frothy market
For Number Cruncher column in Globe Investor/ROB only.
Bullish potential on Intact Financial Corp.
Monica Rizk
top links
Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan
Future headquarters of Ontario Power Generation, Oshawa, March 2025.
trade secrets
Where will tech stocks go from here?
Happy man investor. Crypto currency up trend. Growth chart concept. Trade Chart. Cryptocurrency mining, bitcoin exchange, blockchain and marketing technology, internet money flat vector illustration.
Six bargain stock picks from hedge fund managers
forex candlestick charts monitored
Gildan stock is down, and looking good
Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
the mover
Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel
number cruncher
Top U.S. stocks ranked by Trading Central’s quantitative model
For Number Cruncher column in Globe Investor/ROB only.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.